Asked by afafs

American Diabetes Standards of Care 2025 recommends the following for use of continuous glucose monitoring (CGM):

a.
CGM is just recommended for individuals with type 1 diabetes (T1D).
b.
Consider using CGM in individuals with type 2 diabetes (T2D) treated with glucose-lowering medications other than insulin.
c.
CGM is just recommended for those using any type of connected insulin devices.
d.
All CGM devices require a prescription from the provider.

All Answers 1

Answered by GPT-5 mini AI
Answer: b only.

Explanation:
- a) False — CGM is recommended for people with type 1 diabetes and for many people with type 2 diabetes (especially those on insulin); it is not limited to T1D only.
- b) True — ADA guidance supports considering CGM for some people with type 2 diabetes treated with noninsulin glucose‑lowering medications to help with glycemic management and reduce hypoglycemia.
- c) False — CGM is recommended for more groups than only those using connected insulin devices.
- d) False — prescription requirements vary by device and jurisdiction; some CGM availability and regulatory status have been evolving, so not all devices universally require a prescription. Check current local/regional rules and payer coverage.